“…In addition, the spectrum of vaccine recipients in practice is typically wider than that of the healthy, highly responsive on April 30, 2019 by guest http://cvi.asm.org/ vaccine recipients usually selected for efficacy trials. So, from a public health perspective, the impact of vaccination on outcome in the field should be analyzed (2,3,18,22). We believe our study, with its large sample size, is the first to accurately determine the VE of the S 79 mumps virus vaccine.…”